Editorial Guidelines

JHBRR maintains a strict framework for biomedical research to uphold clinical safety, scientific validity, and academic rigor.

1. Submission and Initial Evaluation

• Scope: Medicine, Biomedicine, Public Health, and Pharmacology.

• Plagiarism: Turnitin screening with a threshold <15%.

• Formatting: Manuscripts must include clinical trial registration (if applicable) and ethics declarations.

• Licensing: Distributed under CC BY-NC 4.0 for non-commercial global health exchange.

2. Peer Review Policy

• Confidentiality: Double-blind review is strictly enforced to ensure impartial scientific assessment.

• Timeline: Most reviews are processed within 2 to 4 weeks to ensure timely dissemination of health data.

3. Editorial Decision-Making

• Decisions: Accept, Minor/Major Revision, or Reject based on peer consensus and clinical relevance.

• Resubmission: Authors must respond to every point raised by the reviewers regarding data interpretation.

4. Ethical Standards

• Clinical Ethics: Research must comply with the Declaration of Helsinki and have proper IRB approvals.

• Conflict of Interest: Mandatory disclosure of all financial ties or pharmaceutical funding.

5. Post-Publication Policy

• Correction: Formal Corrigenda are issued for clinical data errors found post-publication.

• Archiving: Continuous digital preservation for citation durability across global medical databases.